Bryan Johnson, the founder of Braintree and subject of a new Netflix doc, is on a quest for remarkable longevity. Inside most (seemingly) outlandish perspectives lie kernels of truth—and sometimes the ...
Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings EDINBURGH, United Kingdom, Dec. 10, 2025 (GLOBE NEWSWIRE) -- ...
Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a ...
The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...
The FDA has granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...
In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, professor and chairman of ...
Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...
On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
In this video from the American Academy of Ophthalmology meeting, Jennifer I. Lim, MD, MBA, discusses three gene therapies currently being studied for the treatment of age-related macular degeneration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback